DOJ Announces $2 Billion Healthcare Fraud Takedown: What Physicians and Healthcare Providers Need to Know

Federal prosecutors charge 15 defendants, including six medical professionals, in sweeping healthcare fraud enforcement action.

The Department of Justice announced on October 22, 2026, that federal prosecutors in Los Angeles charged 15 defendants, including six medical professionals, in a sweeping healthcare fraud takedown involving approximately $2 billion in allegedly fraudulent healthcare claims.

The cases involve allegations of medically unnecessary procedures, fraudulent hospice certifications, sham substance abuse treatment programs, illegal patient referrals, and improper Medicare billing.

Although the charges were brought in California, the announcement has significant implications for physicians, medical directors, healthcare business owners, and other medical professionals throughout Georgia.

For healthcare providers, the announcement reinforces an important reality: Federal healthcare fraud investigations increasingly focus not only on billing practices but also on medical necessity, physician certifications, patient referrals, and the business relationships underlying healthcare services.

What Did the DOJ Announce?

According to the October 22, 2026, announcement from the U.S. Attorney’s Office for the Central District of California, the cases include several significant alleged fraud schemes:

• More than $1.6 billion in claims involving purported substance abuse treatment programs that allegedly recruited vulnerable patients and billed private insurers for sham treatment.
• Approximately $135 million in alleged Medicare fraud involving unnecessary invasive arterial procedures.
• More than $138 million in alleged fraudulent hospice claims involving patients who allegedly were not terminally ill.
• A separate indictment involving an alleged $270 million Medi-Cal prescription fraud scheme.

The allegations encompass multiple healthcare sectors and involve physicians, medical professionals, facility operators, and others accused of participating in fraudulent billing arrangements.

Physicians Under Scrutiny for Medically Unnecessary Procedures

One of the most significant cases involves a cardiothoracic surgeon and a chiropractor accused of participating in a scheme to bill Medicare for medically unnecessary arterial procedures.

Federal prosecutors allege that patients underwent atherectomies—procedures designed to remove plaque from arteries—even when the patients did not have the underlying arterial disease that would justify treatment. The government further alleges that the defendants submitted claims under the names of medical providers who had not actually performed the procedures and offered improper inducements to Medicare beneficiaries.

According to the DOJ, investigators identified the case through data analytics showing that one physician was an extreme outlier in Medicare billing for atherectomy procedures.

Why This Matters for Georgia Physicians

Federal investigators routinely examine Medicare and Medicaid billing data to identify providers whose practices differ significantly from those of their peers. They use this data from these analytical reports to draw conclusions that are not always true. But, it does trigger additional scrutiny.

A physician may legitimately perform more procedures than peers because of specialization, patient population, referral patterns, or other medically appropriate circumstances. The distinction between aggressive billing, documentation deficiencies, medical disagreement, and intentional fraud can be critical in a federal criminal investigation.

The government must establish the elements of the charged offense, including the required fraudulent intent. Hiring an experienced healthcare fraud defense lawyer early on in an investigation is very important.

Hospice Fraud Investigations: The Risks for Medical Directors and Certifying Physicians

The DOJ announcement also highlights federal scrutiny of hospice providers and physicians who certify patients as terminally ill.

Under Medicare’s hospice benefit, eligibility generally requires physician certification that a patient has a life expectancy of six months or less if the illness runs its normal course.

Federal prosecutors allege that certain defendants enrolled patients who were not terminally ill and submitted claims for hospice services that were unnecessary or not provided.

One case involves a physician accused of signing certifications of terminal illness for beneficiaries who allegedly did not qualify for hospice care and, in some instances, did not know they had been enrolled.

Can a Physician Face Criminal Charges for Signing Hospice Certifications?

Potentially, yes.

A physician who knowingly falsifies a certification to facilitate fraudulent Medicare reimbursement may face criminal liability. But the legal analysis is not as simple as determining whether a patient ultimately survived longer than six months. Hospice eligibility involves a prospective clinical judgment based on the patient’s condition at the time of certification.

A patient living beyond the anticipated prognosis does not, by itself, establish that the original certification was fraudulent.

In defending physicians accused of hospice fraud, important questions may include:

• What clinical information was available when the certification was signed?
• Did the physician personally evaluate the patient or rely on information supplied by other healthcare professionals?
• Were the medical records consistent with the physician’s judgment?
• Did the physician know that any supporting documentation was inaccurate?
• Was the physician involved in the hospice company’s billing, ownership, or financial operations?

These distinctions may determine whether the evidence supports a criminal fraud allegation or instead reflects a disagreement about medical judgment, documentation, or regulatory compliance.

Substance Abuse Treatment Fraud and Illegal Patient Referrals

The largest alleged scheme announced by the DOJ Health care Fraud Section involves more than $1.6 billion in claims connected to purported substance abuse treatment programs.

Prosecutors allege that operators and recruiters targeted vulnerable individuals, offered financial and other inducements, and arranged for patients to receive treatment that was unnecessary, inadequate, or never provided.

The indictment also includes charges under the Eliminating Kickbacks in Recovery Act (EKRA).

EKRA generally prohibits knowingly and willfully offering, paying, soliciting, or receiving remuneration to induce referrals to recovery homes, clinical treatment facilities, or laboratories, subject to statutory exceptions. Unlike the federal Anti-Kickback Statute, which generally focuses on federal healthcare program business, EKRA can reach arrangements involving private insurance.

That distinction is particularly important for substance abuse treatment centers, laboratories, and other covered healthcare businesses.

Why EKRA Matters for Healthcare Businesses

Healthcare providers and treatment facilities should carefully evaluate financial arrangements involving patient recruiters, marketing companies, referral sources, and outside contractors.

Depending on the circumstances, compensation arrangements tied to patient referrals or the volume of reimbursable services can create significant criminal exposure.

Not every marketing arrangement or referral relationship is illegal. The structure of the compensation, the services actually provided, the applicable statutory exceptions, and the parties’ intent all matter.

Federal Healthcare Fraud Investigations Are Increasingly Data-Driven

Perhaps one of the most important aspects of the DOJ announcement is its express reliance on data analytics.

Federal investigators can analyze claims data to identify patterns involving procedure frequency, billing volume, provider relationships, patient characteristics, and reimbursement activity.

Those patterns may prompt investigations long before a physician or healthcare business learns that federal authorities are examining its practices.

A healthcare fraud investigation may involve multiple agencies, including the FBI, the Department of Health and Human Services Office of Inspector General (HHS-OIG), and IRS Criminal Investigation.

Investigators may seek medical records, billing data, financial documents, employee communications, and evidence concerning the provider’s knowledge and intent.

Healthcare professionals should understand that an investigation can begin with billing data rather than a patient complaint or whistleblower allegation. At Conaway & Strickler, PC, we have forensic experts ready to assist in your defense.

What Should a Georgia Physician Do if Contacted by Federal Investigators?

A physician or healthcare business owner who receives a federal grand jury subpoena, search warrant, or request for an interview should contact us immediately.

Even when the provider believes the underlying billing or medical decisions were appropriate, statements made during an investigation may have significant consequences.

Counsel can evaluate the nature of the investigation, determine whether the provider is a witness, subject, or target, address privilege and document-production issues, and help protect the provider’s rights.

Relevant records should be preserved. Providers should not alter medical records, delete communications, or attempt to influence witnesses.

The Difference Between Healthcare Fraud and Medical Judgment

One of the most important questions in any federal healthcare fraud prosecution is whether the government can establish that the defendant knowingly and willfully participated in a fraudulent scheme.

Federal healthcare regulations are complex. Billing errors, coding disputes, incomplete documentation, and disagreements about medical necessity do not automatically constitute criminal fraud.

Under 18 U.S.C. § 1347, the federal healthcare fraud statute requires proof of a knowing and willful scheme to defraud a healthcare benefit program, or to obtain its money or property through materially false or fraudulent representations, in connection with healthcare benefits, items, or services.

The government’s burden is not satisfied merely by showing that a physician made a mistake or that an insurer later disagreed with a treatment decision.

The particular facts, medical evidence, communications, and evidence of intent are essential.

Federal Healthcare Fraud Defense Attorneys in Atlanta, Georgia

The DOJ’s October 22, 2026, healthcare fraud takedown demonstrates the breadth of federal enforcement activity targeting physicians, healthcare executives, treatment facilities, and medical businesses.

For Georgia healthcare professionals, allegations involving Medicare billing, medical necessity, hospice certifications, patient referrals, or healthcare business relationships can carry substantial criminal and professional consequences.

Conaway & Strickler, PC represents individuals and professionals facing federal criminal investigations and prosecutions, including matters involving healthcare fraud and complex financial allegations.

If you are a physician, medical director, healthcare executive, or other medical professional facing a federal investigation, obtaining experienced legal representation early can be critical to protecting your rights and professional future. Contact Conaway & Strickler, PC, at 404 816 5000. We are here to help.

This article is for informational purposes only and does not constitute legal advice.